Discover more from Courageous Discourse™ with Dr. Peter McCullough & John Leake
Number of Vaccine Doses During Neonatal Period and Infancy and Mortality in Children at 1 and 5 Years
Ecological Analysis Suggest Worldwide Mass Vaccination for Childhood Illnesses Could be Backfiring
By Peter A. McCullough, MD, MPH
When ACIP panel added the experimental mRNA vaccines for infants age 6 months and older, it triggered concerns that ACIP may not have ever had adequate intent for risk mitigation or re-evaluation of the ever expanding vaccine schedule. Many have had reservations for a long time and have felt drowned out by the medical orthodoxy of “more vaccines are better.” Now an analysis by Miller, et al, suggests the entire program of hyper vaccination may be backfiring.
The two main independent variables in this analysis restricted to developed countries at two time points 2019 and 2021 (check for internal validity) were the number of vaccines given in the 28 day neonatal period (none, hepatitis B, Bacille Calmette-Guérin (BCG) for tuberculosis) and then the overall number of shots given before age 1 year. The outcome variable was all cause mortality at age 1 and 5 years.
As you can see this does not look good for vaccines. In every analysis the children who went “natural” with no shots did the best and there was a trend for the fewest number of injections to be associated with the lowest mortality. I was born in 1962, so I received zero shots in the neonatal period and a total of 6 doses for four diseases (diphtheria, tetanus, pertussis, polio) before the age of 1 years. As you can see the optimal number of infant doses in the vaccine schedule is <14. The current US ACIP schedule is ~23 doses by year one—a proxy for national intent for hyper vaccination.
This paper has all the limitations of an ecological analysis where individual child record information is not available. The exact configuration of specific vaccines and causes of death are not specified. Thus we can only conclude from this study that “less is more” and countries should consider a risk stratified approach. The two main neonatal vaccines, hepatitis B and BCG should be reconsidered altogether according to individual risk of hepatitis B and tuberculosis, respectively.
Please subscribe to Courageous Discourse as a paying or founder member so we can continue to bring you the truth.
Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Peter A. McCullough, MD, MPH
President, McCullough Foundation
Miller NZ, Goldman GS. Neonatal, Infant, and Under Age Five Vaccine Doses Routinely Given in Developed Nations and Their Association With Mortality Rates. Cureus. 2023 Jul 20;15(7):e42194. doi: 10.7759/cureus.42194. PMID: 37484788; PMCID: PMC10358295.